We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA issued a Sept. 8 warning letter to California-based General Medical Company following an inspection that revealed the firm’s manufacturing practices were not in conformity with the quality system (QS) regulation.